PMID- 31913757 OWN - NLM STAT- MEDLINE DCOM- 20210122 LR - 20210122 IS - 1939-4586 (Electronic) IS - 1059-1524 (Print) IS - 1059-1524 (Linking) VI - 31 IP - 5 DP - 2020 Mar 1 TI - TGFbeta receptor endocytosis and Smad signaling require synaptojanin1, PI3K-C2alpha-, and INPP4B-mediated phosphoinositide conversions. PG - 360-372 LID - 10.1091/mbc.E19-11-0662 [doi] AB - Phosphoinositide conversion regulates a diverse array of dynamic membrane events including endocytosis. However, it is not well understood which enzymes are involved in phosphoinositide conversions for receptor endocytosis. We found by small interfering RNA (siRNA)-mediated knockdown (KD) that class II PI3K alpha-isoform (PI3K-C2alpha), the 5'-phosphatase synaptojanin1 (Synj1), and the 4'-phosphatase INPP4B, but not PI3K-C2beta, Synj2, or INPP4A, were required for TGFbeta-induced endocytosis of TGFbeta receptor. TGFbeta induced rapid decreases in PI(4,5)P(2) at the plasma membrane (PM) with increases in PI(4)P, followed by increases in PI(3,4)P(2), in a TGFbeta receptor kinase ALK5-dependent manner. TGFbeta induced the recruitment of both synaptojanin1 and PI3K-C2alpha to the PM with their substantial colocalization. Knockdown of synaptojanin1 abolished TGFbeta-induced PI(4,5)P(2) decreases and PI(4)P increases. Interestingly, PI3K-C2alpha KD abolished not only TGFbeta-induced PI(3,4)P(2) increases but also TGFbeta-induced synaptojanin1 recruitment to the PM, PI(4,5)P(2) decreases, and PI(4)P increases. Finally, the phosphoinositide conversions were necessary for TGFbeta-induced activation of Smad2 and Smad3. These observations demonstrate that the sequential phosphoinositide conversions mediated by Synj1, PI3K-C2alpha, and INPP4B are essential for TGFbeta receptor endocytosis and its signaling. FAU - Aki, Sho AU - Aki S AD - Department of Physiology, Kanazawa University School of Medicine, Kanazawa, Ishikawa 920-8640, Japan. FAU - Yoshioka, Kazuaki AU - Yoshioka K AD - Department of Physiology, Kanazawa University School of Medicine, Kanazawa, Ishikawa 920-8640, Japan. FAU - Takuwa, Noriko AU - Takuwa N AD - Department of Health Science, Ishikawa Prefectural University, Kahoku, Ishikawa 929-1210, Japan. FAU - Takuwa, Yoh AU - Takuwa Y AD - Department of Physiology, Kanazawa University School of Medicine, Kanazawa, Ishikawa 920-8640, Japan. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20200108 PL - United States TA - Mol Biol Cell JT - Molecular biology of the cell JID - 9201390 RN - 0 (Nerve Tissue Proteins) RN - 0 (Phosphatidylinositols) RN - 0 (Receptors, Transforming Growth Factor beta) RN - 0 (Smad Proteins) RN - 0 (Transforming Growth Factor beta) RN - EC 2.7.11.30 (ACVRL1 protein, human) RN - EC 2.7.11.30 (Activin Receptors, Type II) RN - EC 2.7.11.30 (Receptor, Transforming Growth Factor-beta Type I) RN - EC 2.7.11.30 (TGFBR1 protein, human) RN - EC 3.1.3.- (synaptojanin) RN - EC 3.1.3.2 (Phosphoric Monoester Hydrolases) RN - EC 3.1.3.66 (phosphatidylinositol-3,4-bisphosphate 4-phosphatase) SB - IM MH - Activin Receptors, Type II/metabolism MH - Cell Membrane/metabolism MH - Cell Nucleus/metabolism MH - *Endocytosis MH - Human Umbilical Vein Endothelial Cells/metabolism MH - Humans MH - Nerve Tissue Proteins/*metabolism MH - Phosphatidylinositol 3-Kinases/*metabolism MH - Phosphatidylinositols/*metabolism MH - Phosphoric Monoester Hydrolases/*metabolism MH - Phosphorylation MH - Receptor, Transforming Growth Factor-beta Type I/metabolism MH - Receptors, Transforming Growth Factor beta/*metabolism MH - *Signal Transduction MH - Smad Proteins/*metabolism MH - Transforming Growth Factor beta/metabolism PMC - PMC7183790 EDAT- 2020/01/09 06:00 MHDA- 2021/01/23 06:00 PMCR- 2020/05/16 CRDT- 2020/01/09 06:00 PHST- 2020/01/09 06:00 [pubmed] PHST- 2021/01/23 06:00 [medline] PHST- 2020/01/09 06:00 [entrez] PHST- 2020/05/16 00:00 [pmc-release] AID - E19-11-0662 [pii] AID - 10.1091/mbc.E19-11-0662 [doi] PST - ppublish SO - Mol Biol Cell. 2020 Mar 1;31(5):360-372. doi: 10.1091/mbc.E19-11-0662. Epub 2020 Jan 8.